Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “asthma”

Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonistsRecruiting
NCT07546981Phase 3Updated Jul 8, 2026
Sponsor: Chiesi Farmaceutici S.p.A.
Asthma
China
A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in ItalyRecruiting
NCT07214753N/AUpdated Jul 8, 2026
Sponsor: AstraZeneca
Severe Eosinophilic Asthma
Italy
The Extended Salford Lung Study ("Ex-SLS") Data Access ProjectCompleted
NCT03152669N/AUpdated Jul 7, 2026
Sponsor: GlaxoSmithKline
Asthma
United Kingdom
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe AsthmaActive Not Recruiting
NCT05851443Phase 2Updated Jul 7, 2026
Sponsor: Incyte Corporation
Moderate to Severe Asthma
United States, Argentina, Canada, Germany, Japan +2 more
Fasenra: An Asthma StudyNot Yet Recruiting
NCT07654842Phase 4Updated Jul 7, 2026
Sponsor: Endeavor Health
Eosinophilic Asthma · Severe Asthma · Severe Eosinophilic Asthma · Asthma
United States
Airway Redox and Gender Determinants in Severe AsthmaActive Not Recruiting
NCT01759186N/AUpdated Jul 7, 2026
Sponsor: The Cleveland Clinic
Asthma
United States
Quantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment ResponseRecruiting
NCT07602192N/AUpdated Jul 7, 2026
Sponsor: Korea University Guro Hospital
Asthma (Diagnosis) · COPD (Chronic Obstructive Pulmonary Disease)
South Korea
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)Completed
NCT01117116NAUpdated Jul 6, 2026
Sponsor: National Jewish Health
Asthma
United States
A Trial Evaluating Novel Technologies for the Diagnosis of Asthma The LUNG-TECH TrialRecruiting
NCT05819944N/AUpdated Jul 6, 2026
Sponsor: Portsmouth Hospitals NHS Trust
Asthma
United Kingdom
Implementation of Evidence-based Breathing Retraining for Patients With Asthma in Region ZealandActive Not Recruiting
NCT05531370NAUpdated Jul 2, 2026
Sponsor: Naestved Hospital
Asthma
Denmark
SMART@Home Feasibility TrialRecruiting
NCT06159127NAUpdated Jul 2, 2026
Sponsor: Children's Hospital Medical Center, Cincinnati
Asthma · Asthma in Children
United States
Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary PatternCompleted
NCT05251402Phase 2, Phase 3Updated Jul 2, 2026
Sponsor: University of Illinois at Chicago
Asthma
United States
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe AsthmaCompleted
NCT06376045Phase 2Updated Jul 2, 2026
Sponsor: Amgen
Asthma
United States, Argentina, Australia, Bulgaria, Canada +14 more
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)Completed
NCT04609904Phase 3Updated Jul 2, 2026
Sponsor: AstraZeneca
Asthma
United States, Brazil, China, Colombia, Czechia +11 more
Treating Exacerbations of Asthma With Oral Montelukast in ChildrenCompleted
NCT05819541Phase 2Updated Jul 2, 2026
Sponsor: Vanderbilt University Medical Center
Status Asthmaticus
United States
TGF-(Beta) and Susceptibility to RSVCompleted
NCT01224691N/AUpdated Jul 2, 2026
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Asthma
United States
Depemokimab Asthma Imaging and Bronchoscopy Sub-StudyRecruiting
NCT06979323Phase 3Updated Jul 2, 2026
Sponsor: GlaxoSmithKline
Asthma
United States, Belgium, Canada, China, France +7 more
A Study of CDX-622 in Participants With Mild to Moderate AsthmaRecruiting
NCT07330778Phase 1Updated Jul 2, 2026
Sponsor: Celldex Therapeutics
Mild to Moderate Asthma
United States
Protocol CAUSE-03 / CHEETAHRecruiting
NCT06136091N/AUpdated Jul 1, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Asthma
United States
Novel Method for Removal of Orally Deposited Inhaled Fluticasone PropionateNot Yet Recruiting
NCT07664527Phase 4Updated Jul 1, 2026
Sponsor: University of Wisconsin, Madison
Asthma
United States
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)Completed
NCT04699604Phase 3Updated Jul 1, 2026
Sponsor: Bridgette Jones
Allergic Asthma
United States
The Impact of Anxiety/Depression on the Efficacy of Asthma Control Drugs and the Construction of a Predictive Model for the Risk of Acute Asthma AttacksRecruiting
NCT07679321N/AUpdated Jul 1, 2026
Sponsor: Xiangya Hospital of Central South University
Anxiety/Depression and Asthma
China
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung DiseaseRecruiting
NCT06985225N/AUpdated Jul 1, 2026
Sponsor: University of Kansas Medical Center
Severe Asthma · COPD · Non-CF Bronchiectasis · Cystic Fibrosis (CF)
United States
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaActive Not Recruiting
NCT06676319Phase 2Updated Jul 1, 2026
Sponsor: Sanofi
Asthma
United States, Argentina, Belgium, Brazil, Canada +17 more
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller MedicationTerminated
NCT01875003Phase 3Updated Jun 30, 2026
Sponsor: Hoffmann-La Roche
Asthma
United States, Argentina, Brazil, Canada, Colombia +16 more

Previous page Next page